Poseida Therapeutics

company

About

Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

  • 251 - 500

Details

Last Funding Type
Series A
Last Funding Money Raised
$23M
Industries
Biopharma,Biotechnology,Genetics,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
251 - 500
Operating Status
Active

Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.

Poseida Therapeutics was founded in 2014 and is headquartered in San Diego, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$206.66M
Poseida Therapeutics has raised a total of $206.66M in funding over 2 rounds. Their latest funding was raised on Apr 22, 2019 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 22, 2019 Series C $142M 1 Detail
Apr 3, 2018 Series B $30.50M 1 Detail
Aug 2, 2017 Series A $11.16M 1 Malin Corporation Detail
Dec 23, 2015 Series A $23M 1 Malin Corporation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Poseida Therapeutics is funded by 1 investors. Malin Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
Malin Corporation Series C